| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.23 | 0.3 |